BCL2 and acute myeloid leukemia: Due to their central role in maintaining mitochondrial integrity, antiapoptotic BCL-2 proteins represent important therapeutic targets in cancer5, and the potential of BH3-mimetics to induce apoptosis in AML has been elucidated by multiple studies6–11.